全文获取类型
收费全文 | 355689篇 |
免费 | 4223篇 |
国内免费 | 1224篇 |
专业分类
电工技术 | 6400篇 |
综合类 | 246篇 |
化学工业 | 53887篇 |
金属工艺 | 14863篇 |
机械仪表 | 10519篇 |
建筑科学 | 8823篇 |
矿业工程 | 2066篇 |
能源动力 | 9300篇 |
轻工业 | 31379篇 |
水利工程 | 3758篇 |
石油天然气 | 6659篇 |
武器工业 | 12篇 |
无线电 | 40351篇 |
一般工业技术 | 69022篇 |
冶金工业 | 66820篇 |
原子能技术 | 8533篇 |
自动化技术 | 28498篇 |
出版年
2021年 | 2756篇 |
2019年 | 2632篇 |
2018年 | 4390篇 |
2017年 | 4446篇 |
2016年 | 4722篇 |
2015年 | 3199篇 |
2014年 | 5458篇 |
2013年 | 15834篇 |
2012年 | 8993篇 |
2011年 | 12547篇 |
2010年 | 9980篇 |
2009年 | 11542篇 |
2008年 | 11598篇 |
2007年 | 11630篇 |
2006年 | 9948篇 |
2005年 | 9281篇 |
2004年 | 8904篇 |
2003年 | 8498篇 |
2002年 | 8158篇 |
2001年 | 8264篇 |
2000年 | 8025篇 |
1999年 | 8312篇 |
1998年 | 20470篇 |
1997年 | 14645篇 |
1996年 | 11365篇 |
1995年 | 8465篇 |
1994年 | 7480篇 |
1993年 | 7252篇 |
1992年 | 5498篇 |
1991年 | 5335篇 |
1990年 | 5028篇 |
1989年 | 5123篇 |
1988年 | 4935篇 |
1987年 | 4282篇 |
1986年 | 4127篇 |
1985年 | 4862篇 |
1984年 | 4458篇 |
1983年 | 4157篇 |
1982年 | 3777篇 |
1981年 | 3926篇 |
1980年 | 3651篇 |
1979年 | 3692篇 |
1978年 | 3684篇 |
1977年 | 4217篇 |
1976年 | 5621篇 |
1975年 | 3215篇 |
1974年 | 3125篇 |
1973年 | 3188篇 |
1972年 | 2648篇 |
1971年 | 2469篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
101.
102.
N Pasetto V Petrozza C Ticconi A Zicari F Carpino E Piccione M Melis 《Canadian Metallurgical Quarterly》1993,35(2):99-102
Ten patients with biopsy verified chronic hepatitis C virus (HCV) infection were treated with oral ribavirin at a dose of 1,000-1,200 mg per day in two divided doses for 12 weeks. Serum alanine aminotransferase (ALT) levels and hepatitis C viral ribonucleic acid (RNA) levels in serum were followed prior to, during, and 12 weeks posttreatment. ALT levels decreased significantly in all patients during therapy from a mean level of 3.21 mukat/l (range 1.22 to 7.79) before, to 1.25 mukat/l (range 0.78 to 2.04) at the end of treatment (P < 0.005). Hereafter, relapse to pretreatment levels was seen within 12 weeks after treatment stop. The hepatitis C viral RNA levels decreased from a mean 10 log titer of 4.1 (range 1-6) before treatment to 3.4 (range 1-5) at treatment stop. Five patients did not change their HCV RNA titers during treatment. Twelve weeks posttreatment only 3 patients had lower titers than prior to treatment. We conclude that oral ribavirin seems to reduce the viral load, at least temporarily, in some patients with chronic viremic HCV infection. Further studies are needed to evaluate fully the effect of oral ribavirin on chronic HCV infection. 相似文献
103.
The conclusions clinicians have drawn about Holocaust survivors over the last 50 yrs differ sharply from researchers' findings. It is important to evaluate these discrepancies since different perceptions of survivors affect treatment approaches. The researchers' view, stressing the survivor's resilience and resourcefulness, contrasts with clinical impressions centering on a survivor syndrome involving deep emotional disturbances as residues of the Holocaust experience. (PsycINFO Database Record (c) 2010 APA, all rights reserved) 相似文献
104.
Good access to health facilities providing good first-level health care remains problematic in many developing countries. It is a hindrance to effective and efficient functioning of the hospital, as outpatient departments become overcrowded with patients from areas without health centres. In many cases the quality of care delivered to these patients is poor because within the district health system the hospital is not the best place for the supply of comprehensive, integrated and continuous care. Eventually, high hospital involvement in first-level care can jeopardize the delivery of adequate referral care for those patients who desperately need the hospital's technology and expertise. This paper provides an account of the way this problem was investigated and managed by the district health management team in the Murewa district in north-east Zimbabwe. The design of a comprehensive 'master plan' or 'coverage plan' is presented as well as the problems and difficulties encountered. The Murewa experience highlights the relevance of a coverage plan for rational and coherent health infrastructure planning at district level. The approach followed by the Murewa team illustrates the use of action research as an integral part of the management of district health systems. 相似文献
105.
PURPOSE: To develop risk-based recommendations for mammographic screening for women in their 40s that take into account the woman's age, race, and specific risk factors. METHODS: We assumed that regular mammographic screening is justified for a 50-year-old woman, even one with no risk factors, and that a younger woman with an expected 1-year breast cancer incidence rate as great or greater than that of a 50-year-old woman with no risk factors would benefit sufficiently to justify regular screening. Recommendations under this criterion were based on age- and race-specific breast cancer incidence rates from the National Cancer Institute's (NCI's) Surveillance, Epidemiology, and End Results (SEER) Program; assessments of risk factors from the Breast Cancer Detection and Demonstration Project (BCDDP); and reports in the literature. RESULTS: Two methods, the exact-age procedure (EAP) and the grouped-age procedure (GAP), were developed. The less precise GAP only requires following a flow diagram. The proportion of white women recommended for screening by the EAP ranges from 10% for 40-year-old women to 95% for 49-year-old women, and the corresponding percentages for black women are 16% and 95%. The assumptions that underlie the guidelines are discussed critically. CONCLUSION: For women or physicians who prefer an individualized approach in deciding whether to initiate regular mammographic screening in the age range of 40 to 49 years, the present report offers recommendations based on individualized risk-factor data and clearly stated assumptions that have an empiric basis. These recommendations can be used to facilitate the counseling process. 相似文献
106.
E Campagnutta R Cannizzaro M De Cicco G De Piero G Giorda F Sopracordevole A Parin C Scarabelli 《Canadian Metallurgical Quarterly》1998,50(7-8):305-311
BACKGROUND AND AIMS: Intestinal obstruction is a frequent cause of death in patients suffering from gynecological cancer, who have undergone multiple treatment in the form of surgery and/or chemotherapy and/or radiotherapy. The usual form of rescue treatment consists in the use of a nasogastric tube to administer support and analgesic treatment. Surgical gastrostomy is not a viable proposition in these extremely weak patients with large masses compressing and displacing the stomach. Percutaneous endoscopic gastrostomy (PEG), a technique first introduced for nutritional purposes, can be beneficially used to achieve decompression in these patients. METHODS: PEG was performed in a total of 67 patients who had already undergone multiple treatment for abdominal-pelvic neoplasia with upper gastrointestinal obstruction, who could no longer be operated and who had a life expectancy of less than sixty days. In three cases positioning was not possible owing to the lack of transillumination of the gastric and abdominal wall. 54/64 patients had previously undergone at least two operations. RESULTS: Esophagogastric lesions were found in 29% of patients, some of which were attributed to the nasogastric tube. Symptomatic wellbeing was obtained in 76.5% a few days after PEG. PEG remained in situ from 4 to 472 days. Slight peristomal infection was observed in 9% of cases. In seven cases it was necessary to add octreotide owing to the reappearance of symptoms. CONCLUSIONS: PEG is relatively easy to use and allows obstructive symptoms to be resolved in the majority of patients. Special medical skills are not required and the patient may be easily managed at home together with support therapy and pain management. Once PEG has been performed, it is possible to take fluids and semi-liquid foods, offering the patient a chance to taste flavours which have often been forgotten. PEG enables neoadjuvant chemotherapy to be performed in patients with previously untreated intestinal obstruction. 相似文献
107.
E Arvat R Giordano J Ramunni G Arnaldi A Colao R Deghenghi G Lombardi F Mantero F Camanni E Ghigo 《Canadian Metallurgical Quarterly》1998,83(12):4207-4211
We previously reported that in Cushing's disease (CD) the ACTH- and cortisol (F)-releasing activity of Hexarelin (HEX), a GH secretagogue, is exaggerated with respect to that in normal subjects and is higher than that of human CRH (hCRH), but it is absent in Cushing's syndrome. Our aim was to extend the study about the effects of HEX (2.0 microg/kg, iv) on ACTH and F secretion in 21 patients with CD (3 men and 18 women, 16-68 yr old). Based on magnetic resonance imaging, 15 CD patients had pituitary microadenoma, and 6 had macroadenoma. The results in CD patients were compared with those in 27 normal age-matched controls (NS; 10 men and 17 women, 24-69 yr old). Basal ACTH and F levels in CD were similar in patients with microadenom (mean+/-SEM, 78.3+/-7.2 pg/mL and 237.1+/-23.6 microg/L, respectively) and macroadenoma (57.4+/-9.0 pg/mL and 196.9+/-20.1 microg/L, respectively) and were higher (P < 0.001) than those in NS (17.7+/-2.0 pg/mL and 115.3+/-6.7 microg/L, respectively). In microadenoma CD patients, HEX induced marked ACTH and F increases (delta peak, mean+/-SEM: 261.2+/-77.6 pg/mL and 226.1+/-87.2 microg/L, respectively), which were higher (P < 0.04) than those induced by hCRH (45.6+/-16.9 pg/mL and 84.6+/-25.7 microg/L, respectively). Moreover, in microadenoma CD patients, the ACTH and F responses to HEX were higher (P < 0.001) than those in NS (18.5+/-4.0 pg/mL and 36.1+/-6.8 microg/L, respectively). In macroadenoma CD patients, HEX induced a slight, but significant increase (P < 0.02) in ACTH and F levels (33.9+/-18.0 pg/mL and 89.6+/-34.3 microg/L, respectively), which was not significantly different from that elicited by hCRH (20.0+/-7.0 pg/mL and 54.8+/-21.3 microg/L, respectively). In macroadenoma CD patients, the ACTH and F responses to HEX and hCRH were, in turn, similar to those in NS. In conclusion, our findings demonstrate that the ACTH and F hyperresponsiveness to HEX is present in Cushing's disease with micro-, but not macro- ACTH-secreting pituitary adenoma. This finding agrees with other evidence pointing toward differences in the hormonal behavior between micro- and ACTH-secreting pituitary macroadenomas. 相似文献
108.
109.
110.
Chewing and acid on the tongue evoked a flow of saliva from the duct-cannulated parotid gland of the conscious rat despite pretreatment with atropine and adrenoceptor antagonists. This non-adrenergic, non-cholinergic (NANC) response depended on an intact parasympathetic innervation and was abolished by a tachykinin antagonist. The present findings are consistent with a physiological role for the secretory NANC mechanisms of the salivary glands. 相似文献